menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

FDA: Taking Action Against Marketing Unapproved Drugs

close
FDA: Taking Action Against Marketing Unapproved Drugs
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    What specific action is the FDA undertaking to combat the marketing of unapproved drugs, and how can healthcare professionals play a role in tackling this public health issue? Dr. Charles Lee, a medical officer within the Division of New Drugs and Labeling Compliance at the Center for Drug Evaluation and Research, speaks with host Dr. Charles Turck about the FDA's top priorities in corralling products that pose key safety concerns, or do not measure up to efficacy standards or manufacturing practices.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    What specific action is the FDA undertaking to combat the marketing of unapproved drugs, and how can healthcare professionals play a role in tackling this public health issue? Dr. Charles Lee, a medical officer within the Division of New Drugs and Labeling Compliance at the Center for Drug Evaluation and Research, speaks with host Dr. Charles Turck about the FDA's top priorities in corralling products that pose key safety concerns, or do not measure up to efficacy standards or manufacturing practices.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/25/20